Borderline hypertension

Clinical and Experimental Hypertension

Volumn 21, Issue 5-6, 1999, Pages 741-747

  Julius, Stevo ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cardiovascular risk; Epidemiology

Indexed keywords

AMBULATORY MONITORING; BLOOD PRESSURE MONITORING; BORDERLINE HYPERTENSION; CONFERENCE PAPER; CORONARY RISK; HUMAN; MORTALITY; PREVALENCE;

EID: 0032783088     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969909061004     Document Type: Conference Paper

References (26)

1. Julius, S., Schork, M.A. Borderline hypertension - a critical review. J Chronic Dis. 1971; 23: 723-754.
2. Neaton, J.D., Kuller, L., Stamler, J., Wentworth, D.N. Impact of systolic and diastolic blood pressure on cardiovascular mortality. In: ed. Laragh, J.H., Brenner, B.M. Hypertension: Pathophysiology, Diagnosis, and Management, Raven Press, Ltd, New York: 1995, 127-144.
3. Julius, S., Jamerson, K., Mejia, A., Krause, L., Schork, N., Jones, K. The association of borderline hypertension with target organ changes and higher coronary risk. Tecumseh Blood Pressure Study. JAMA. 1990; 264: 354-358.
4. Lund-Johansen, P., Omvik, P. Hemodynamic patterns of untreated hypertensive disease. In: ed. Laragh, J.H., Brenner, B.M. Hypertension: Pathophysiology, Diagnosis, and Management, Raven Press, Ltd., New York: 1990, 305-327.
5. Ellis, C.N., Julius, S. Role of central blood volume in hyperkinetic borderline hypertension. Br Heart J. 1973; 35: 450-455.
6. Esler, M., Julius, S., Zweifler, A., et al. Mild high-renin essential hypertension: Neurogenic human hypertension? N Engl J Med. 1977; 296: 405-411.
7. Kjeldsen, S.E., Gjesdal, K., Eide, I., et al. Increased beta-thromboglobulin in essential hypertension: Interactions between arterial plasma adrenaline, platelet function and blood lipids. Acta Med Scand. 1983; 213: 369-373.
8. Julius, S., Esler, M. Autonomic nervous cardiovascular regulation in borderline hypertension. Am J Cardiol. 1975; 36: 685-696.
9. Julius, S., Pascual, A.V., London, R. Role of parasympathetic inhibition in the hyperkinetic type of borderline hypertension. Circulation. 1971; 44: 413-418.
10. Julius, S., Krause, L., Schork, N., et al. Hyperkinetic borderline hypertension in Tecumseh, Michigan. J Hypertens. 1991; 9: 77-84.
11. Julius, S., Schork, N., Schork, A. Sympathetic hyperactivity in early stages of hypertension: The Ann Arbor data set. J Cardiovasc Pharmacol. 1988; 12(Suppl. 3): S121-S129.
12. Schork, N.J., Weder, A.B., Schork, M.A., Bassett, D.R., Julius, S. Disease entities, mixed multi-normal distributions, and the role of the hyperkinetic state in the pathogenesis of hypertension. Statistics in Medicine. 1990; 9: 301-314.
13. Anderson, E.A., Sinkey, C.A., Lawton, W.J., Mark, A.L. Elevated sympathetic nerve activity in borderline hypertensive humans: Evidence from direct intraneural recordings. Hypertension. 1989; 14: 177-183.
14. Esler, M., Jennings, G., Biviano, B., Lambert, G., Hasking, G. Mechanism of elevated plasma noradrenaline in the course of essential hypertension. J Cardiovasc Pharmacol. 1986; 8(Suppl. 5): S39-S43.
15. Mancia, G., Saino, A., Grassi, G. Interactions between the sympathetic nervous system and the renin angiotensin system. In: ed. Laragh, J.H., Brenner, B.M. Hypertension. Pathophysiology, Diagnosis, and Management, Raven Press, New York: 1995, 399-407.
16. Palatini, P., Julius, S. Heart rate and the cardiovascular risk. J Hypertens. 1997; 15: 1-15.
17. Palatini, P., Casiglia, E., Pauletto, P., Staessen, J., Kaciroti, N., Julius, S. Relationship of tachycardia with high blood pressure and metabolic abnormalities. A study with mixture analysis in three populations. Hypertension. 1997; 30: 1267-1273.
18. Lown, B., Verrier, R.L. Neural activity and ventricular fibrillation. N Engl J Med. 1976; 294: 1165-1170.
19. Julius, S. Sympathetic hyperactivity and coronary risk in hypertension (Corcoran Lecture). Hypertension. 1993; 21,6: 886-893.
20. Julius, S., Gudbrandsson, T., Jamerson, K., Shahab, S.T., Andersson, O. Hypothesis. The hemodynamic link between insulin resistance and hypertension. J Hypertens. 1991; 9: 983-986.
21. Jamerson, K.A., Julius, S., Gudbrandsson, T., Andersson, O., Brant, D.O. Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension. 1993; 21(5): 618-623.
22. Levy, D., Garrison, R.J., Savage, D.D., Kannel, W.B., Castelli, W.P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med. 1990; 322: 1561-1566.
23. Folkow, B. Physiological aspects of primary hypertension. Physiol Rev. 1982; 62: 347-503.
24. Harrap, S.B., Van der Merwe, W.M., Griffin, S.A., Macpherson, F., Lever, A.F. Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term. Hypertension. 1990; 16(6): 603-614.
25. Australian National Blood Pressure Study, The Australian therapeutic trial in mild hypertension. Lancet. 1980; 1: 1261-1267.
26. Nesbitt, S.D., Amerena, J.V., Grant, E., et al. Home blood pressure as a predictor of future blood pressure stability in borderline hypertension. The Tecumseh Study. Am J Hypertens. 1997; 10: 1270-1280.